ask="1.9900"
ask_size="700"
average_daily_volume="43883"
bid="N/A"
bid_size="N/A"
book_value="0.8110"
change="+0.0199"
change_from_200_day_moving_average="0.0211"
change_from_50_day_moving_average="-0.0532"
change_from_52_week_high="-2.0001"
change_From_52_week_low="0.4599"
change_in_percent="+1.1988%"
close="1.6799"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.2600"
ebitda="-6.98M"
eps_estimate_current_year="-0.1600"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.4800"
ex_dividend_date="N/A"
float_shares="2843000"
high="1.7500"
high_52_weeks="3.6800"
last_trade_date="3/8/2017"
last_trade_price="1.6799"
last_trade_size="100"
last_trade_time="3:59pm"
low="1.6200"
low_52_weeks="1.2200"
market_capitalization="18.46M"
moving_average_200_day="1.6588"
moving_average_50_day="1.7331"
name="Cleveland BioLabs
Inc."
notes="N/A"
one_year_target_price="2.0000"
open="1.6900"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+1.2745%"
percent_change_from_50_day_moving_average="-3.0719%"
percent_change_from_52_week_high="-54.3505%"
percent_change_from_52_week_low="+37.6967%"
previous_close="1.6600"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.0469"
price_per_sales="4.8019"
revenue="3.80M"
shares_outstanding="10987000"
short_ratio="0.1100"
stock_exchange="NCM"
symbol="CBLI"
volume="20516"
weeks_range_52="1.2200 - 3.6800"
